Clinical Research

With increasing requirements from institutional review boards (IRBs) and governmental agencies, partnering with CIL for your next stable isotope cGMP project can help ensure your regulatory compliance. With the world’s largest 13C and 18O isotope-separation plants, CIL is able to provide the raw materials necessary for your project. Your compound of interest most likely already appears in CIL’s extensive list of research compounds – if not, CIL’s team of PhD chemists can determine the best method of synthesis for incorporating 13C, deuterium, 15N, 17O and/or 18O into your compound. CIL has manufactured bulk active pharmaceutical ingredients (APIs) since 1994. It recently added a 15,000-square-foot, state-of-the-art cGMP facility to complement its existing cGMP facilities.

Clinical Research
 

ReseaChem GmbH
Pestalozzistrasse 16 • CH-3400 Burgdorf/Switzerland • nfrschmch • Tel: ++41 34 424 03 10 • Fax: ++41 34 424 03 12

ReseaChem GmbH
Pestalozzistrasse 16 • CH-3400 Burgdorf/Switzerland • nfrschmch
Tel: ++41 34 424 03 10 • Fax: ++41 34 424 03 12

 
 

ReseaChem GmbH
Pestalozzistrasse 16
CH-3400 Burgdorf/Switzerland
nfrschmch
Tel: ++41 34 424 03 10
Fax: ++41 34 424 03 12


©2016 ReseaChem GmbH / all rights reserved.